Janet Woodcock (Sipa via AP Images)

FDA's Janet Wood­cock to re­tire in ear­ly 2024

Janet Wood­cock, an FDA leg­end who for al­most 40 years served as act­ing FDA com­mis­sion­er, deputy com­mis­sion­er and CDER di­rec­tor, among oth­er roles, will re­tire ear­ly next year, she con­firmed to End­points News via email.

Wood­cock’s shoes will be dif­fi­cult to fill as she has served as the face of just about every drug ap­proval de­ci­sion at the agency since the turn of the cen­tu­ry, bring­ing decades of ex­pe­ri­ence with her. Dur­ing the pan­dem­ic she served in a wider role, as she ro­tat­ed be­tween the top of the drugs cen­ter at the FDA to the head of ther­a­peu­tics at Op­er­a­tion Warp Speed, lead­ing the dri­ve for work on Covid-tar­get­ed mAbs and an­tivi­rals.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.